Colistin Resistance and ESBL Production in Salmonella and Escherichia coli from Pigs and Pork in the Thailand, Cambodia, Lao PDR, and Myanmar Border Area

The study aimed to examine the prevalence and genetic characteristics of ESBL-production and colistin resistance in and from pigs and pork in the border area among Thailand, Cambodia, Lao PDR, and Myanmar. ( = 463) and ( = 767) isolates were collected from pig rectal swab from slaughterhouses ( = 44...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antibiotics (Basel) 2021-05, Vol.10 (6), p.657
Hauptverfasser: Lay, Khin Khin, Jeamsripong, Saharuetai, Sunn, Kyaw Phyoe, Angkititrakul, Sunpetch, Prathan, Ransiya, Srisanga, Songsak, Chuanchuen, Rungtip
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The study aimed to examine the prevalence and genetic characteristics of ESBL-production and colistin resistance in and from pigs and pork in the border area among Thailand, Cambodia, Lao PDR, and Myanmar. ( = 463) and ( = 767) isolates were collected from pig rectal swab from slaughterhouses ( = 441) and pork from retail markets ( = 368) during October 2017 and March 2018. All were determined for susceptibility to colistin and cephalosporins, ESBL production and and ESBL genes. was predominantly found in Cambodia (65.8%). Serovars Rissen (35.6%) and Anatum (15.3%) were the most common. The prevalence in pork was above 91% in all countries. Colistin-resistance rate in (10.4%) was significantly higher than (2.6%). ESBL-producing (1.9%) and (6.3%) were detected. The and were identified. The gene was detected in ( = 12) and ( = 68). The / and / co-concurrence was observed in one and three isolates, respectively. In conclusion, pigs and pork serve as carriers of colistin and new generation cephalosporins resistance. Testing for resistance to last line antibiotics should be included in national AMR surveillance program using One Health approach.
ISSN:2079-6382
2079-6382
DOI:10.3390/antibiotics10060657